The future of technologies for personalised medicine

Alison Harvey, Angela Brand, Stephen T. Holgate, Lars V. Kristiansen, Hans Lehrach, Aarno Palotie, Barbara Prainsack

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Personalised medicine promises prediction, prevention and treatment of illness that is targeted to individuals' needs. New technologies for detailed biological profiling of individuals at the molecular level have been crucial in initiating the move to personalised medicine; further novel technologies will be necessary if the vision is to become a reality. We will need to develop new technologies to collect and analyse data in a way that is not just linear but integrated (understanding system level functioning) and dynamic (understanding system in flux). Key factors in the development of technologies for personalised medicine are standardisation, integration and harmonisation. For example, the tools and processes for data collection and analysis must be standardised across research sites. Research activity at different sites must be integrated to maximise synergies, and scientific research must be integrated with healthcare to ensure effective translation. There must also be harmonisation between scientific practices in different research sites, between science and healthcare and between science, healthcare and wider society, including the ethical and regulatory frameworks, the prevailing political and cultural ethos and the expectations of patients/citizens.

Original languageEnglish
Pages (from-to)625-633
Number of pages9
JournalNew Biotechnology
Volume29
Issue number6
DOIs
Publication statusPublished - 15-09-2012

Fingerprint

Precision Medicine
Medicine
Technology
Delivery of Health Care
Research
Standardization
Fluxes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Molecular Biology

Cite this

Harvey, A., Brand, A., Holgate, S. T., Kristiansen, L. V., Lehrach, H., Palotie, A., & Prainsack, B. (2012). The future of technologies for personalised medicine. New Biotechnology, 29(6), 625-633. https://doi.org/10.1016/j.nbt.2012.03.009
Harvey, Alison ; Brand, Angela ; Holgate, Stephen T. ; Kristiansen, Lars V. ; Lehrach, Hans ; Palotie, Aarno ; Prainsack, Barbara. / The future of technologies for personalised medicine. In: New Biotechnology. 2012 ; Vol. 29, No. 6. pp. 625-633.
@article{5e7f1df77de3465d9b3958bf4938e31a,
title = "The future of technologies for personalised medicine",
abstract = "Personalised medicine promises prediction, prevention and treatment of illness that is targeted to individuals' needs. New technologies for detailed biological profiling of individuals at the molecular level have been crucial in initiating the move to personalised medicine; further novel technologies will be necessary if the vision is to become a reality. We will need to develop new technologies to collect and analyse data in a way that is not just linear but integrated (understanding system level functioning) and dynamic (understanding system in flux). Key factors in the development of technologies for personalised medicine are standardisation, integration and harmonisation. For example, the tools and processes for data collection and analysis must be standardised across research sites. Research activity at different sites must be integrated to maximise synergies, and scientific research must be integrated with healthcare to ensure effective translation. There must also be harmonisation between scientific practices in different research sites, between science and healthcare and between science, healthcare and wider society, including the ethical and regulatory frameworks, the prevailing political and cultural ethos and the expectations of patients/citizens.",
author = "Alison Harvey and Angela Brand and Holgate, {Stephen T.} and Kristiansen, {Lars V.} and Hans Lehrach and Aarno Palotie and Barbara Prainsack",
year = "2012",
month = "9",
day = "15",
doi = "10.1016/j.nbt.2012.03.009",
language = "English",
volume = "29",
pages = "625--633",
journal = "New Biotechnology",
issn = "1871-6784",
publisher = "Elsevier",
number = "6",

}

Harvey, A, Brand, A, Holgate, ST, Kristiansen, LV, Lehrach, H, Palotie, A & Prainsack, B 2012, 'The future of technologies for personalised medicine', New Biotechnology, vol. 29, no. 6, pp. 625-633. https://doi.org/10.1016/j.nbt.2012.03.009

The future of technologies for personalised medicine. / Harvey, Alison; Brand, Angela; Holgate, Stephen T.; Kristiansen, Lars V.; Lehrach, Hans; Palotie, Aarno; Prainsack, Barbara.

In: New Biotechnology, Vol. 29, No. 6, 15.09.2012, p. 625-633.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The future of technologies for personalised medicine

AU - Harvey, Alison

AU - Brand, Angela

AU - Holgate, Stephen T.

AU - Kristiansen, Lars V.

AU - Lehrach, Hans

AU - Palotie, Aarno

AU - Prainsack, Barbara

PY - 2012/9/15

Y1 - 2012/9/15

N2 - Personalised medicine promises prediction, prevention and treatment of illness that is targeted to individuals' needs. New technologies for detailed biological profiling of individuals at the molecular level have been crucial in initiating the move to personalised medicine; further novel technologies will be necessary if the vision is to become a reality. We will need to develop new technologies to collect and analyse data in a way that is not just linear but integrated (understanding system level functioning) and dynamic (understanding system in flux). Key factors in the development of technologies for personalised medicine are standardisation, integration and harmonisation. For example, the tools and processes for data collection and analysis must be standardised across research sites. Research activity at different sites must be integrated to maximise synergies, and scientific research must be integrated with healthcare to ensure effective translation. There must also be harmonisation between scientific practices in different research sites, between science and healthcare and between science, healthcare and wider society, including the ethical and regulatory frameworks, the prevailing political and cultural ethos and the expectations of patients/citizens.

AB - Personalised medicine promises prediction, prevention and treatment of illness that is targeted to individuals' needs. New technologies for detailed biological profiling of individuals at the molecular level have been crucial in initiating the move to personalised medicine; further novel technologies will be necessary if the vision is to become a reality. We will need to develop new technologies to collect and analyse data in a way that is not just linear but integrated (understanding system level functioning) and dynamic (understanding system in flux). Key factors in the development of technologies for personalised medicine are standardisation, integration and harmonisation. For example, the tools and processes for data collection and analysis must be standardised across research sites. Research activity at different sites must be integrated to maximise synergies, and scientific research must be integrated with healthcare to ensure effective translation. There must also be harmonisation between scientific practices in different research sites, between science and healthcare and between science, healthcare and wider society, including the ethical and regulatory frameworks, the prevailing political and cultural ethos and the expectations of patients/citizens.

UR - http://www.scopus.com/inward/record.url?scp=84865415689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865415689&partnerID=8YFLogxK

U2 - 10.1016/j.nbt.2012.03.009

DO - 10.1016/j.nbt.2012.03.009

M3 - Article

C2 - 23091837

AN - SCOPUS:84865415689

VL - 29

SP - 625

EP - 633

JO - New Biotechnology

JF - New Biotechnology

SN - 1871-6784

IS - 6

ER -

Harvey A, Brand A, Holgate ST, Kristiansen LV, Lehrach H, Palotie A et al. The future of technologies for personalised medicine. New Biotechnology. 2012 Sep 15;29(6):625-633. https://doi.org/10.1016/j.nbt.2012.03.009